**Immediate Changes in Medication Availability** In light of the FDA's recent statement, Nuceria Pharmacy will cease production of all peptides containing the following active ingredients: - AOD 9604 - BPC-157 - CJC-1295 - Dihexa - DSIP - Epitalon - GHK-Cu (for injectable routes of administration) - Ibutamoren (MK677) - Ipamorelin Acetate - Kisspeptin-10 - KPV - MOTs-C - Selank - Semax We understand the potential implications this might have for your treatment plans
Riechers DE, Irzyk GP, Jones SS, Fuerst EP 1997 Partial characterization of glutathione S-transferases from wheat (Triticum spp.) and purification of a safener-induced glutathione S-transferase from Triticum tauschii
The peptides ability to stimulate connective tissue accumulation and collagen synthesis has been demonstrated in experimental wound models 5
The content below explains the scientific background, proposed research mechanisms, typical application areas, storage expectations, reconstitution considerations where applicable, and quality-control points that support careful experimental planning
BPC 157 is most commonly administered via subcutaneous injections
